There have been reports of a lukewarm response from the FDA’s Circulatory System Devices advisory panel regarding the endorsement of Abbott Laboratories’ MitraClip device.

Final first year results of the Phase 3 trial of relapsing-remitting multiple sclerosis drug Plegridy have been announced by Biogen Idec. After clearing the first test, there has been an indication that it is effective at reducing multiple sclerosis (MS) disease.

It has been unveiled that Samsung is all set to launch its latest Galaxy device. As per media reports, the new device could be launched by the company within a week.

The report has found that New York's Radio City Music Hall is being taken over by Samsung to uncover the device. The company had brushed off Mobile World Congress when it had to stage a show to introduce the new Galaxy S3.

Though, every other part of the gaming universe would be continuing to enjoy hardware manufacturing for PlayStation 2, technically. It has been revealed in a recent report that Sony has taken this opportunity from being used by Japan.

The US Department of Justice is investigating Hewlett-Packard’s (HP) Autonomy unit, as reported on Thursday.

The HP, November, said that it suffered a fraud in accounting that was related to $11.1 billion acquisition of British software specialist Autonomy. The company is almost silent on the matter and is expected that it has nothing more to say about the Autonomy deal in 2013.

Recent reports have subjected that the latest version of Itanium server processor line has been revealed by Intel. The Itanium 9500 series will be offering the users almost 2.4 times higher the performance rate and double the transistors.